Skip to content

FP7

APPROACH

Applied Public-Private Research enabling OsteoArthritis Clinical Headway

Programme
Seventh Framework Programme
Started
Ends
Duration
66 months
Total cost
EUR 17,250,007
EU contribution
EUR 7,500,000
Participants
24 from 11 countries
Topic
FP7_IMI-JU-11-2013-01
Grant agreement
115770

Coordinated by Glaxosmithkline Research & Development Limited (GBUnited Kingdom).

Consortium

EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.

Members of the consortium, coordinator first
OrganisationCountryRoleEU contributionRecognised by
Glaxosmithkline Research & Development LimitedGBUnited KingdomCoordinatorNot statedPIC (1.00)
Medizinische Universitaet WienATAustriaParticipantEUR 190,000PIC (1.00)
Artialis SABEBelgiumParticipantEUR 250,000PIC (1.00)
Friedrich-Alexander-Universitaet Erlangen-NuernbergDEGermanyParticipantEUR 75,000PIC (1.00)
Merck KGaADEGermanyParticipantNot statedPIC (1.00)
Universitatsklinikum ErlangenDEGermanyParticipantEUR 35,000known name (0.97)
Nordic Bioscience Compound Development A/SDKDenmarkParticipantNot statedPIC (1.00)
Servizo Galego de SaudeESSpainParticipantEUR 458,000known name (0.95)
assistance publique hopitaux de parisFRFranceParticipantEUR 178,050name shared with others (0.80)
Centre National de la Recherche Scientifique CnrsFRFranceParticipantEUR 75,000known name (0.95)
Institut de Recherches Internationales ServierFRFranceParticipantNot statedPIC (1.00)
Arthritis Research UKGBUnited KingdomParticipantNot statedPIC (1.00)
European Technology for Business LtdGBUnited KingdomParticipantEUR 185,000PIC (1.00)
Immunodiagnostic Systems Holdings PLCGBUnited KingdomParticipantNot statedPIC (1.00)
University of LeedsGBUnited KingdomParticipantEUR 150,000known name (0.95)
University of SurreyGBUnited KingdomParticipantEUR 400,000known name (0.95)
Academisch Ziekenhuis LeidenNLNetherlandsParticipantEUR 701,010PIC (1.00)
Hemics BVNLNetherlandsParticipantEUR 200,000PIC (1.00)
Stichting LygatureNLNetherlandsParticipantEUR 695,000PIC (1.00)
Stichting ReumaNederlandNLNetherlandsParticipantEUR 112,500PIC (1.00)
Universitair Medisch Centrum UtrechtNLNetherlandsParticipantEUR 2,919,900known name (0.95)
Diakonhjemmet Sykehus AsNONorwayParticipantEUR 163,040PIC (1.00)
MAX IV Laboratory, Lund UniversitySESwedenParticipantEUR 162,500PIC (1.00)
Abbvie IncUSUnited StatesParticipantNot statedPIC (1.00)

Changes of the consortium

First seen on with 24 participants from 11 countries.

A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.

Project page on CORDIS (opens in new tab)

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.